We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

62 hedge funds and large institutions have $69.8M invested in Marrone Bio Innovations, Inc. in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 8

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

12% more capital invested

Capital invested by funds: $62.3M → $69.8M (+$7.49M)

7% more funds holding

Funds holding: 58 → 62 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
25
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
+$1.97M
2
WRF
Waddell & Reed Financial
Kansas
+$1.77M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$546K
4
State Street
State Street
Massachusetts
+$368K
5
BlackRock
BlackRock
New York
+$242K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$157K
2
Goldman Sachs
Goldman Sachs
New York
-$88.2K
3
Primecap Management
Primecap Management
California
-$62.2K
4
RJA
Raymond James & Associates
Florida
-$59K
5
TRCT
Tower Research Capital (TRC)
New York
-$55.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$34K -$55.3K -46,371 -63%
GSC
27
Ground Swell Capital
South Carolina
$30K +$28.7K +24,071 New
Barclays
28
Barclays
United Kingdom
$28K -$9.21K -7,717 -26%
UBS Group
29
UBS Group
Switzerland
$28K +$7.84K +6,574 +43%
VF
30
Virtu Financial
New York
$28K +$26.8K +22,473 New
Victory Capital Management
31
Victory Capital Management
Texas
$27K +$2.09K +1,748 +9%
Citadel Advisors
32
Citadel Advisors
Florida
$27K +$9.68K +8,116 +59%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$26K – – –
CS
34
Credit Suisse
Switzerland
$24K +$22.9K +19,169 New
Bank of America
35
Bank of America
North Carolina
$20K +$9.96K +8,346 +113%
ProShare Advisors
36
ProShare Advisors
Maryland
$19K +$18.3K +15,364 New
Goldman Sachs
37
Goldman Sachs
New York
$17K -$88.2K -73,913 -85%
Principal Financial Group
38
Principal Financial Group
Iowa
$16K +$2.83K +2,372 +23%
Squarepoint
39
Squarepoint
New York
$16K +$15.1K +12,663 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$16K +$15.4K +12,877 New
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$15K +$9.74K +8,163 +260%
Citigroup
42
Citigroup
New York
$15K +$10.3K +8,631 +267%
AF
43
Allworth Financial
California
$14K – – –
AB
44
Amalgamated Bank
New York
$13K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$12.5K -$3.37K -2,823 -22%
AWM
46
Avior Wealth Management
Nebraska
$12K – – –
Legal & General Group
47
Legal & General Group
United Kingdom
$9K – – –
Russell Investments Group
48
Russell Investments Group
United Kingdom
$6K -$157K -131,830 -96%
AIP
49
Ameritas Investment Partners
Nebraska
$6K – – –
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$6K +$5.45K +4,571 +5,936%
1
2
3

MBII Hedge Fund Activity: Q4 2020 in Review

62 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2020, worth a combined $69.8M — up 12% from $62.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBII positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 8 trimmed.

The largest buyer was Ardsley Advisory Partners, adding an estimated $1.97M. The largest seller was Russell Investments Group, cutting an estimated $157K.

  • 62 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2020, up from 58 in Q3 2020.
  • Funds reported $69.8M of Marrone Bio Innovations, Inc. stock for Q4 2020, up 12% quarter-over-quarter.
  • 11 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2020 and 6 closed out, a net change of +5 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q4 2020 was Ardsley Advisory Partners, an estimated $1.97M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q4 2020 was Russell Investments Group, an estimated $157K sold.

Based on aggregated 13F filings for Q4 2020.